Chronic Fatigue Syndrome (CFS), also known as Myalgic Encephalomyelitis (ME), is a complex and debilitating disorder characterized by persistent and severe fatigue that cannot be explained by any underlying medical condition. This condition is not improved by rest and significantly affects a person's ability to carry out daily activities.
The exact cause of CFS remains unknown, although several factors have been suggested as potential contributors, such as viral infections, immune system dysfunction, hormonal imbalances, and genetic predisposition. CFS predominantly affects women in their 40s and 50s and is estimated to affect millions of people worldwide.
The primary symptom of CFS is overwhelming fatigue that persists for at least six months and is not relieved by rest. Other common symptoms include impaired memory and concentration (often referred to as "brain fog"), unrefreshing sleep, muscle and joint pain, sore throat, enlarged lymph nodes, headaches, and a general feeling of malaise. These symptoms may fluctuate in severity and can significantly impact a person's quality of life.
The diagnosis of CFS involves ruling out other potential causes of fatigue through a thorough medical evaluation. Currently, no specific laboratory tests or imaging procedures can definitively diagnose CFS. Treatment for CFS focuses on managing and relieving symptoms, such as cognitive behavioral therapy, graded exercise therapy, and medications to alleviate pain, sleep disturbances, and depression.
Chronic Fatigue Syndrome is a complex and chronic condition that can greatly affect an individual's overall well-being and quality of life. Further research is needed to better understand the underlying mechanisms and to develop more effective treatments for this debilitating disorder.
